Skip to main content

Table 3 Patients at low risk in primary prevention

From: From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial

 

Complex intervention A n = 366

Simple intervention B n = 384

A vs. B

 

Mean FU

95% CI

Mean FU

95% CI

Difference/Odds ratio

95% CI

p

ICC

p

CVR

2.9%

2.7%-3.1%

2.7%

2.5%-2.9%

Δ = 0.2%

-0.1%-0.5%

0.282

0.032

0.043

RR systolic [mmHg]

134.0

132.1-135.9

134.3

132.3-136.2

Δ = -0.2

-2.9-2.5

0.866

0.097

<0.001

RR diastolic [mmHg]

80.9

79.9-82.0

80.7

79.7-81.8

Δ = 0.2

-1.3-1.7

0.798

0.063

<0.001

Control rate RR < 140/90

58.1%

51.3%-64.8%

54.0%

47.1%-60.9%

OR = 1.19

0.78-1.82

0.411

0.098

<0.001

Control rate RR < 160/95

90.2%

86.8%-93.6%

90.7%

87.4%-94.0%

OR = 0.94

0.55-1.62

0.830

0.051

0.205

Cholesterol [mg/dl]

216.6

213.0-220.1

219.3

215.7-222.8

Δ = -2.7

-7.7-2.3

0.294

0.021

0.103

Current smoker

16.2%

12.5%-20.0%

16.4%

12.5%-20.3%

OR = 0.98

0.48-1.99

0.948

0.240

<0.001

ASS

9.0%

7.0%-10.9%

9.2%

7.3%-11.2%

OR = 0.89

0.32-2.43

0.815

0.318

0.001

Statins

18.1%

14.6%-21.6%

13.5%

10.2%-16.7%

OR = 1.89

0.98-3.62

0.056

0.150

0.010

  1. Outcomes at follow up in subpopulation at low CVR (10-year mortality < 5%) with no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.